Short description
Genetic Technologies is a molecular diagnostics company specializing in oncology.
Description
Genetic Technologies is a global molecular diagnostic business with an extensive range of international patents and a portfolio of tests and related services.
Our aim is simple: to concentrate on markets where we can establish a long-term dominant position by providing tests that genuinely affect clinical outcomes. We are already the leading non-government genetic testing business in Australia, and through our wholly owned subsidiary Phenogen Sciences, we now have a solid and growing presence in the USA.
We remain committed to the development of a global portfolio of cancer management tests. The first of which is the Breast Cancer Risk Assessment Test, BREVAGenTM.
Last funding
Noaccess
Sign in for full access
Total funding
$$2020202
Sign in for full access
Location
Fitzroy, Victoria, Australia, Oceania
Founded on
January 1, 1987
Exited on
July 21, 1998
Went public on
July 21, 1998
Stock symbol
GENE
Non-profit?
No
Acquired?
No
Employees count
101-250
Revenue range
$34056 - 789030
Sign in for full access
Investors
Noaccess
Sign in for full access